Fragile sites are preferential targets for integrations of MLV vectors in gene therapy (vol 13, pg 1057, 2006)

被引：0
|
作者：
Bester, A. C.
Schwartz, M.
Schmidt, M.
Garrigue, A.
Hacein-Bey-Abina, S.
Cavazzana-Calvo, M.
Ben-Porat, N.
Von Kalle, C.
Fischer, A.
Kerem, B.
机构：
来源：
GENE THERAPY | 2007年 / 14卷 / 03期
关键词：
D O I：
10.1038/sj.gt.3302904
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Correction to: Gene Therapy (2006) 13, 1057–1059. doi:10.1038/sj.gt.3302752 Since the above publication the authors have noticed an error in the first DNA marker of FRA11E in Supplementary Table 1S. The correct table is shown below: The authors would like to apologise for this error.
引用
收藏
页码：282 / 282
页数：1
相关论文
共 45 条
  • [1] Fragile sites are preferential targets for integrations of MLV vectors in gene therapy
    Bester, A. C.
    Schwartz, M.
    Schmidt, M.
    Garrigue, A.
    Hacein-Bey-Abina, S.
    Cavazzana-Calvo, M.
    Ben-Porat, N.
    Von Kalle, C.
    Fischer, A.
    Kerem, B.
    [J]. GENE THERAPY, 2006, 13 (13) : 1057 - 1059
  • [2] Fragile sites are preferential targets for integrations of MLV vectors in gene therapy
    A C Bester
    M Schwartz
    M Schmidt
    A Garrigue
    S Hacein-Bey-Abina
    M Cavazzana-Calvo
    N Ben-Porat
    C Von Kalle
    A Fischer
    B Kerem
    [J]. Gene Therapy, 2006, 13 : 1057 - 1059
  • [3] Erratum: Fragile sites are preferential targets for integrations of MLV vectors in gene therapy
    A C Bester
    M Schwartz
    M Schmidt
    A Garrigue
    S Hacein-Bey-Abina
    M Cavazzana-Calvo
    N Ben-Porat
    C Von Kalle
    A Fischer
    B Kerem
    [J]. Gene Therapy, 2007, 14 : 282 - 282
  • [4] Common fragile sites are preferential targets for HPV16 integrations in cervical tumors
    Erik C Thorland
    Shannon L Myers
    Bobbie S Gostout
    David I Smith
    [J]. Oncogene, 2003, 22 : 1225 - 1237
  • [5] Common fragile sites are preferential targets for HPV16 integrations in cervical tumors
    Thorland, EC
    Myers, SL
    Gostout, BS
    Smith, DI
    [J]. ONCOGENE, 2003, 22 (08) : 1225 - 1237
  • [6] Biology of AAV serotype vectors in liver-directed gene transfer to nonhuman primates (vol 13, pg 77, 2006)
    Gao, Guangping
    Lu, You
    Calcedo, Roberto
    Grant, Rebecca L.
    Bell, Peter
    Wang, Lili
    Figueredo, Joanita
    Lock, Martin
    Wilson, James M.
    [J]. MOLECULAR THERAPY, 2006, 14 (01) : 150 - 150
  • [7] Viral Vectors in Gene Replacement Therapy (vol 88, pg 2157, 2023)
    Minskaia, Ekaterina
    Galieva, Alima
    Egorov, Alexander D.
    Ivanov, Roman
    Karabelsky, Alexander
    [J]. BIOCHEMISTRY-MOSCOW, 2024, 89 (03) : 583 - 583
  • [8] Gene therapy in orthopaedics (vol 37, pg S30, 2006)
    Giannoudis, Peter V.
    Tzioupis, Christopher C.
    Tsiridis, Eleftherios
    [J]. INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 2006, 37 (09): : 926 - 926
  • [9] The P53 Gene And Human Vestibular Schwannomas (vol 13, pg 77, 2006)
    Dayalan, Antony H. P. P.
    Keshava, Rohini
    Jothi, Mathivanan
    Gope, Mohan L.
    Gope, Rajalakshmi
    [J]. ANNALS OF NEUROSCIENCES, 2006, 13 (04)
  • [10] Vectors for Inhaled Gene Therapy in Lung Cancer. Application for Nano Oncology and Safety of Bio Nanotechnology (vol 13, pg 10828, 2012)
    Zarogoulidis, Paul
    Karamanos, Nikos K.
    Porpodis, Konstantinos
    Domvri, Kalliopi
    Huang, Haidong
    Hohenforst-Schmidt, Wolfgang
    Goldberg, Eugene P.
    Zarogoulidis, Konstantinos
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2012, 13 (12) : 17290 - 17291
12345